These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19405794)

  • 21. [Tigecycline--a new antibiotic].
    Skibeli V; Aaløkken I; Lingaas E; Midtvedt T; Solberg CO; Melby KK
    Tidsskr Nor Laegeforen; 2010 Aug; 130(16):1624-6. PubMed ID: 20805861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline.
    Falagas ME; Karageorgopoulos DE; Dimopoulos G
    Curr Drug Metab; 2009 Jan; 10(1):13-21. PubMed ID: 19149509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline for the treatment of infections due to resistant Gram-positive organisms.
    Squires RA; Postier RG
    Expert Opin Investig Drugs; 2006 Feb; 15(2):155-62. PubMed ID: 16433594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance.
    Pournaras S; Koumaki V; Spanakis N; Gennimata V; Tsakris A
    Int J Antimicrob Agents; 2016 Jul; 48(1):11-18. PubMed ID: 27256586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline: Alone or in combination?
    Cai Y; Bai N; Liu X; Liang B; Wang J; Wang R
    Infect Dis (Lond); 2016 Jul; 48(7):491-502. PubMed ID: 26982103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 30. Tigecycline: a new antibiotic.
    Hylands J
    Intensive Crit Care Nurs; 2008 Aug; 24(4):260-3. PubMed ID: 18554910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.
    Tasina E; Haidich AB; Kokkali S; Arvanitidou M
    Lancet Infect Dis; 2011 Nov; 11(11):834-44. PubMed ID: 21784708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline treatment of critically ill patients: the LatinUser experience.
    Curcio D; Vargas SW; Ugarte Ubiergo S; Varón F; Rojas Suarez J; Paz Chávez C; Curiale A;
    Curr Clin Pharmacol; 2011 Feb; 6(1):18-25. PubMed ID: 21235466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage.
    Chen LY; Chen TC; Chen YH; Lin CY; Lin WR; Lu PL
    J Microbiol Immunol Infect; 2011 Oct; 44(5):352-7. PubMed ID: 21524975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era.
    Ziglam H
    Expert Opin Pharmacother; 2007 Oct; 8(14):2279-92. PubMed ID: 17927483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic impact simulation analysis of use of tigecycline, as appropriate, in first-course antibiotic therapy for complicated intra-abdominal infections in intensive care patients.
    Ancona F
    Minerva Med; 2010 Oct; 101(5):319-28. PubMed ID: 21048554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.
    Grolman DC
    Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tigecycline in the treatment of infections in light of the new black box warning.
    Dixit D; Madduri RP; Sharma R
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):397-400. PubMed ID: 24597542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.